Mayo Clinic ophthalmologist Wayne Wu explains how diabetes can damage the retina, why routine screening matters and what symptoms need prompt attention.

An advice column describes how different eating paces changed a six-woman dinner group and suggests ways to make room for longer conversation.

The FDA approved asundexian with antiplatelet therapy for some adults after ischemic stroke or high-risk TIA, based on OCEANIC-Stroke results.

The FDA is requiring GLP-1 drug labels to warn of a potential increased risk of NAION, a rare eye condition that can cause lasting vision loss.

A Hong Kong study of more than 120,000 older adults found bisphosphonate users had lower dementia rates, but it cannot show the drugs caused the difference.

A Huberman Lab episode with Stanford addiction specialist Anna Lembke examines dopamine, compulsive behavior, control and recovery resources.